X0306 4 2015-03-19 0 0001088856 CORCEPT THERAPEUTICS INC CORT 0001024003 COOK JOSEPH C JR C/O CORCEPT THERAPEUTICS INCORPORATED 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 1 0 0 0 Common Stock 2015-03-19 4 X 0 145480 2.77 A 2186306 D Common Stock 2015-03-19 4 S 0 77200 5.22 D 2109106 D Common Stock 2015-03-19 4 X 0 14402 2.77 A 249164 I See footnotes (2) and (3) Common stock 2015-03-19 4 S 0 7643 5.22 D 241521 I See footnotes (2) and (3) Common stock 2015-03-19 4 X 0 13995 2.77 A 363995 I See footnotes (4) and (5) Common stock 2015-03-19 4 S 0 7427 5.22 D 356568 I See footnotes (4) and (5) Warrant (Right to Buy) 2.77 2015-03-19 4 X 0 31570 0.00 D 2009-02-06 2015-03-24 Common Stock 31570 88261 D Warrant (Right to Buy) 2.77 2015-03-19 4 X 0 88261 0.00 D 2008-03-25 2015-03-24 Common Stock 88261 0 D Warrant (Right to Buy) 2.77 2015-03-19 4 X 0 25649 0.00 D 2009-02-06 2015-03-24 Common Stock 25649 0 D Warrant (Right to Buy) 2.77 2015-03-19 4 X 0 14402 0.00 D 2009-02-06 2015-03-24 Common Stock 14402 0 I See footnote (2) Warrant (Right to Buy) 2.77 2015-03-19 4 X 0 13995 0.00 D 2009-02-06 2015-03-24 Common Sotck 13995 0 I See footnote (4) On March 19, 2015, the reporting person exercised warrants to purchase 145,480 shares of the Issuer's common stock for an exercise price of $2.77 per share. The reporting person paid the exercise prices on a cashless basis, resulting in the Issuer's withholding of 77,200 of such shares to pay the exercise price and issuing the remaining 68,280 shares to the reporting person. On March 19, 2015, Farview Management, Co. L.P. (Farview) exercised a warrant to purchase 14,402 shares of the Issuer's common stock for an exercise price of $2.77 per share. Farview paid the exercise price on a cashless basis, resulting in the Issuer withholding 7,643 of such shares to pay the exercise price and issuing to Farview the remaining 6,759 shares. Reflects transactions and holdings of shares of common stock of the Issuer held of records by Farview Management, Co. L.P., of which the reporting person is a general partner. On March 19, 2015, the Judith E. and Joseph C. Cook, Jr. Foundation, Inc., or Cook Foundation, exercised a warrant to purchase 13,995 shares of the Issuer's common stock for an exercise price of $2.77 per share. The Cook Foundation paid the exercise price on a cashless basis, resulting in the Issuer's withholding 7,427 of such shares to pay the exercise price and issuing to the Cook Foundation the remaining 6,568 shares. Mr. Cook and Judith E. Cook may be deemed to have shared voting and investment power over the shares held by the Cook Foundation. Each of these individuals disclaims beneficial ownership of all such shares, except to the extent of his or her pecuniary interest therein. Reflects transactions and holdings of shares of common stock of the Issuer held of record by the Cook Foundation. /s/ Joseph K. Belanoff, CEO of Corcept Therapeutics Incorporated attorney-in-fact 2015-03-25